Rating Change
Needham analysts reiterated a Buy rating on Glaukos Corporation (NYSE:GKOS) on July 30, 2026.
reiterateNYSE:GKOS
Needham Reiterates Buy Rating on Glaukos Corporation (GKOS)
Rating Change Needham analysts reiterated a Buy rating on Glaukos Corporation (NYSE:GKOS) on July 30, 2026. Market Context Glaukos Corporation operates in the Healthcare sector.…
Market Context
Glaukos Corporation operates in the Healthcare sector. The stock currently trades at $166.65 with a market capitalization of $6.3B.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Glaukos Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Glaukos Corporation
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 30, 2026 | Wells Fargo | Overweight | N/A |
| Jul 30, 2026 | Needham | Buy | N/A |
| Jul 30, 2026 | BTIG | Buy | N/A |
| Jul 17, 2026 | Stifel | Buy | N/A |
| Jul 16, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View GKOS Stock Page
Frequently Asked Questions
What does a Buy rating mean for GKOS?
A Buy rating from Needham reflects the analyst's outlook on Glaukos Corporation (NYSE:GKOS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GKOS forecast page.